[
  {
    "ts": null,
    "headline": "Vertex to Announce First Quarter 2025 Financial Results on May 5th",
    "summary": "BOSTON, April 07, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2025 financial results on Monday, May 5, 2025 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the \"Vertex Pharmaceuticals First Quarter 2025 Earnings Call.\"",
    "url": "https://finnhub.io/api/news?id=a0fe305f872139c172bf33a9d1c08655871b1ca553162b16b7e7ef03b497e809",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744056300,
      "headline": "Vertex to Announce First Quarter 2025 Financial Results on May 5th",
      "id": 133764218,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "BOSTON, April 07, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2025 financial results on Monday, May 5, 2025 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the \"Vertex Pharmaceuticals First Quarter 2025 Earnings Call.\"",
      "url": "https://finnhub.io/api/news?id=a0fe305f872139c172bf33a9d1c08655871b1ca553162b16b7e7ef03b497e809"
    }
  },
  {
    "ts": null,
    "headline": "European Commission Approves Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis",
    "summary": "LONDON, April 07, 2025--Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in a combination regimen with ivacaftor for the treatment of people with cystic fibrosis (CF). With this approval, the indication has been expanded to include all patients ages 2 years and older who have at least one non-class I mutation in the cystic fibrosis conductance regulator (CFTR) ge",
    "url": "https://finnhub.io/api/news?id=034a639c9b5b8cab24b0309d8e6eb7d028879b62cb52deffa34ff0c80f15345f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744041600,
      "headline": "European Commission Approves Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis",
      "id": 133741192,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "LONDON, April 07, 2025--Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in a combination regimen with ivacaftor for the treatment of people with cystic fibrosis (CF). With this approval, the indication has been expanded to include all patients ages 2 years and older who have at least one non-class I mutation in the cystic fibrosis conductance regulator (CFTR) ge",
      "url": "https://finnhub.io/api/news?id=034a639c9b5b8cab24b0309d8e6eb7d028879b62cb52deffa34ff0c80f15345f"
    }
  },
  {
    "ts": null,
    "headline": "2 Stocks to Buy if You're Worried About a Recession",
    "summary": "If a recession does hit, it might also affect the stock market, and different companies and sectors will perform differently.  Let's consider two stocks that should handle recessions better than most and are worth investing in for the long haul: Vertex Pharmaceuticals (NASDAQ: VRTX) and HCA Healthcare (NYSE: HCA).  Vertex Pharmaceuticals is best known for developing cystic fibrosis (CF) drugs.",
    "url": "https://finnhub.io/api/news?id=eabc0a463c15e1b2f5e63462eb9122dcfde4013eb8de829385f34e9462e9621a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744017840,
      "headline": "2 Stocks to Buy if You're Worried About a Recession",
      "id": 133738848,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "If a recession does hit, it might also affect the stock market, and different companies and sectors will perform differently.  Let's consider two stocks that should handle recessions better than most and are worth investing in for the long haul: Vertex Pharmaceuticals (NASDAQ: VRTX) and HCA Healthcare (NYSE: HCA).  Vertex Pharmaceuticals is best known for developing cystic fibrosis (CF) drugs.",
      "url": "https://finnhub.io/api/news?id=eabc0a463c15e1b2f5e63462eb9122dcfde4013eb8de829385f34e9462e9621a"
    }
  },
  {
    "ts": null,
    "headline": "Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4",
    "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at therapeutics stocks, starting with United Therapeutics (NASDAQ:UTHR).",
    "url": "https://finnhub.io/api/news?id=922a7fed6ecec9fae98a03a43b28da7c8701769aba7ee86f5b515f84f347e991",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744017091,
      "headline": "Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4",
      "id": 133738849,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at therapeutics stocks, starting with United Therapeutics (NASDAQ:UTHR).",
      "url": "https://finnhub.io/api/news?id=922a7fed6ecec9fae98a03a43b28da7c8701769aba7ee86f5b515f84f347e991"
    }
  }
]